EAM
YARW

Eventide Asset Management’s Yarrow Bioscience YARW Stock Holding History

Eventide Asset Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,887
Closed -$2.37M – 256
2025
Q1 		$2.37M Hold
27,887
– – 0.05% 159
2024
Q4 		$4.45M Hold
27,887
– – 0.08% 156
2024
Q3 		$3.13M Hold
27,887
– – 0.05% 148
2024
Q2 		$3.13M Hold
27,887
– – 0.05% 141
2024
Q1 		$3.13M Hold
27,887
– – 0.05% 141
2023
Q4 		$3.25M Buy
+27,887
New +$4.35M 0.05% 137
2018
Q2 		– Sell
-7
Closed -$940K – 151
2018
Q1 		$940K Buy
+7
New +$851K 0.04% 134

Other funds holding YARW

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Eventide Asset Management's YARW Position: Q2 2025 in Review

Eventide Asset Management sold out of Yarrow Bioscience (YARW) in Q2 2025, closing a stake of 27,887 shares — an estimated $2.37M sold.

Eventide Asset Management first reported a position in YARW in Q1 2018 and held it in 7 quarters. The position peaked at $4.45M in Q4 2024. 44 funds tracked by Wall St. Rank hold YARW as of Q2 2025.

  • Eventide Asset Management reported no remaining Yarrow Bioscience position as of Q2 2025 after selling out during the quarter.
  • Eventide Asset Management sold 27,887 Yarrow Bioscience shares in Q2 2025, an estimated $2.37M.
  • Eventide Asset Management first reported a position in Yarrow Bioscience in Q1 2018 and held it in 7 quarters.
  • Eventide Asset Management's Yarrow Bioscience position peaked at $4.45M in Q4 2024.
  • 44 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2025.

Based on Eventide Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.